{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:18Z","timestamp":1760955378815,"version":"3.40.4"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1987,10,1]],"date-time":"1987-10-01T00:00:00Z","timestamp":560044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1987,10]]},"DOI":"10.1007\/bf03259953","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T10:26:54Z","timestamp":1354184814000},"page":"338-366","source":"Crossref","is-referenced-by-count":33,"title":["Aspirin, Paracetamol and Non-Steroidal Anti-Inflammatory Drugs"],"prefix":"10.1007","volume":"2","author":[{"given":"P. D.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"key":"BF03259953_CR1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(68)91280-4","volume":"1","author":"C Abrahams","year":"1968","unstructured":"Abrahams C, Levin NW. Analgesic nephropathy. Lancet 1: 645, 1968","journal-title":"Lancet"},{"key":"BF03259953_CR2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0002-9343(53)90377-5","volume":"14","author":"JF Ackroyd","year":"1953","unstructured":"Ackroyd JF. Allergic purpura including purpura due to foods, drugs and infections. American Journal of Medicine 14: 603, 1953","journal-title":"American Journal of Medicine"},{"key":"BF03259953_CR3","first-page":"243","volume-title":"Antirheumatic Drugs","author":"SS Adams","year":"1983","unstructured":"Adams SS, Warwick-Buckler J. Ibuprofen and flurbiprofen. In Huskisson EC (Ed.) Antirheumatic Drugs, pp. 243\u2013264, Praeger Publishers, Eastbourne, 1983"},{"key":"BF03259953_CR4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/bmj.284.6316.631","volume":"284","author":"SM Akyol","year":"1982","unstructured":"Akyol SM, Thompson M, Kerr DNS. Renal function after prolonged consumption of aspirin. British Medical Journal 284: 631\u2013632, 1982","journal-title":"British Medical Journal"},{"key":"BF03259953_CR5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/bmj.283.6306.1611","volume":"283","author":"SG Allen","year":"1981","unstructured":"Allen SG, Knox J, Kerr F. Interaction between diuretics and indomethacin. British Medical Journal 283: 1611, 1981","journal-title":"British Medical Journal"},{"key":"BF03259953_CR6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(87)90499-5","volume":"1","author":"JG Ayres","year":"1987","unstructured":"Ayres JG, Fleming DM, Whittington RM. Asthma death due to ibuprofen. Lancet 1: 1082, 1987","journal-title":"Lancet"},{"key":"BF03259953_CR7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9343(84)90849-0","volume":"76","author":"WL Bender","year":"1984","unstructured":"Bender WL, Whelton A, Beschorner WE, Darwish MO, Hall-Craggs M, et al. Interstitial nephritis, proteinuria and renal failure caused by NSAIDs. American Journal of Medicine 76: 1006\u20131012, 1984","journal-title":"American Journal of Medicine"},{"key":"BF03259953_CR8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/bmj.4.5939.263","volume":"4","author":"RA Billings","year":"1974","unstructured":"Billings RA, Burry HC, Emslie FS, Kerr GD. Vasculitis with alclofenac therapy. British Medical Journal 4: 263\u2013265, 1974.","journal-title":"British Medical Journal"},{"key":"BF03259953_CR9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jama.1973.03220170041009","volume":"224","author":"Boston Collaborative Drug Surveillance Program","year":"1973","unstructured":"Boston Collaborative Drug Surveillance Program. Drug induced deafness: a cooperative study. Journal of the American Medical Association 224: 515\u2013516, 1973","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/j.1552-4604.1981.tb05677.x","volume":"21","author":"DC Brater","year":"1981","unstructured":"Brater DC, Fox WR Chennavasin P. Interaction studies with bumetanide and furosemide: effects of probenecid and indomethacin on response to bumetanide in man. Journal of Clinical Pharmacology 21: 647\u2013653, 1981","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259953_CR11","first-page":"326","volume":"5","author":"PG Brock","year":"1982","unstructured":"Brock PG, Jackson D. UK general practitioners experience of fenbufen in elderly patients. European Journal of Inflammation 5: 326\u2013331, 1982","journal-title":"European Journal of Inflammation"},{"key":"BF03259953_CR12","first-page":"55","volume-title":"Antirheumatic drugs","author":"WW Buchanan","year":"1983","unstructured":"Buchanan WW, Rooney PJ, Rennie JAN. Aspirin and the salicylates. In Huskisson EC (Ed.) Antirheumatic drugs, pp. 55\u201395, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3565(25)05276-0","volume":"109","author":"JJ Burns","year":"1953","unstructured":"Burns JJ, Rose RK, Chenkin T, Goldman A, Schulert A, et al. Physiology disposition of phenylbutazone (butazolidin) in man and method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 109: 346\u2013357, 1953","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259953_CR14","first-page":"135","volume-title":"Renal infection and renal scarring","author":"AF Burry","year":"1971","unstructured":"Burry AF. The pathology and pathogenesis of renal papillary necrosis. In Kincaid-Smith & Fairley (Eds) Renal infection and renal scarring, p. 135, Mercedes, Melbourne, 1971"},{"key":"BF03259953_CR15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.31.1.65","volume":"31","author":"HC Burry","year":"1972","unstructured":"Burry HC. Reduced glomerular function in rheumatoid arthritis. Annals of the Rheumatic Diseases 31: 65\u201368, 1972","journal-title":"Annals of the Rheumatic Diseases"},{"key":"BF03259953_CR16","first-page":"233","volume-title":"Antirheumatic drugs","author":"RAP Burt","year":"1983","unstructured":"Burt RAP, Gruber CM, Irons MR. Fenoprofen calcium: a review. In Huskisson EC (Ed.) Antirheumatic drugs, pp. 233\u2013242, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1185\/03007997809110207","volume":"5","author":"R Buxton","year":"1978","unstructured":"Buxton R, Grennan DM, Palmer DG. Fenbufen compared with indomethacin in osteoarthritis. Current Medical Research and Opinion 5: 682\u2013687, 1978","journal-title":"Current Medical Research and Opinion"},{"doi-asserted-by":"crossref","unstructured":"Cardoe N. A review of long-term experience with ibuprofen, with special reference to gastric tolerance. Rheumatology and Physical Medicine (Suppl.): 28\u201331, 1970","key":"BF03259953_CR18","DOI":"10.1093\/rheumatology\/X.suppl_1.28"},{"unstructured":"Cardoe N, Fowler PD. Diclofenac sodium (Voltarol R): a double-blind comparative study with ibuprofen in patients with rheumatoid arthritis. Rheumatology and Rehabilitation (Suppl. 2): 89\u201399, 1979","key":"BF03259953_CR19"},{"key":"BF03259953_CR20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/0002-9343(85)90223-2","volume":"79","author":"J Carmichael","year":"1985","unstructured":"Carmichael J, Skankel SW. Effects of non-steroidal anti-inflammatory drugs on prostaglandins and renal function. American Journal of Medicine 79: 992\u20131000, 1985","journal-title":"American Journal of Medicine"},{"key":"BF03259953_CR21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0022215100092367","volume":"96","author":"P Chapman","year":"1982","unstructured":"Chapman P. Naproxen and sudden hearing loss. Journal of Laryngology and Otology 96: 163\u2013166, 1982","journal-title":"Journal of Laryngology and Otology"},{"key":"BF03259953_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198402023100502","volume":"310","author":"G Ciabatoni","year":"1984","unstructured":"Ciabatoni G, Cinotti G, Pierucci A, et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. New England Journal of Medicine 310: 279\u2013283, 1984","journal-title":"New England Journal of Medicine"},{"unstructured":"Ciccolunghi SN, Schubiger BI, Reddrop R. Comparison of tolerability in international clinical trials. Rheumatology and Rehabilitation (Suppl. 2): 122-134, 1979","key":"BF03259953_CR23"},{"unstructured":"Ciucci A. A review of spontaneously reported adverse drug reactions. Rheumatology and Rehabilitation (Suppl. 2): 116-121, 1979","key":"BF03259953_CR24"},{"key":"BF03259953_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJM198403013100905","volume":"310","author":"DM Clive","year":"1984","unstructured":"Clive DM, Stoff JS. Renal syndromes associated with non-steroidal anti-inflammatory drugs. New England Journal of Medicine 310: 163\u2013572, 1984","journal-title":"New England Journal of Medicine"},{"unstructured":"Cohen PM. A report on the incidences of rash in an open study investigating safety and efficacy of fenbufen in the treatment of 8,640 patients. Data on file, Lederle, 1986","key":"BF03259953_CR26"},{"key":"BF03259953_CR27","first-page":"31","volume-title":"Practical problems in rheumatology. International Congress Symposium Series No. 32","author":"HLF Currey","year":"1980","unstructured":"Currey HLF. Side effects. In Practical problems in rheumatology. International Congress Symposium Series No. 32, p. 31, Royal Society of Medicine, London, 1980"},{"key":"BF03259953_CR28","first-page":"181","volume":"45","author":"M Davis","year":"1976","unstructured":"Davis M, Simmons CJ, Harrison NG, Williams R. Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage. Quarterly Journal of Medicine 45: 181\u2013191, 1976","journal-title":"Quarterly Journal of Medicine"},{"key":"BF03259953_CR29","first-page":"421","volume":"40","author":"GG Bono De","year":"1986","unstructured":"De Bono GG, Pearlgood M. General practice trials: a reappraisal in the light of the findings of a general practice study of Oruvail. British Journal of Clinical Practice 40: 421\u2013428, 1986","journal-title":"British Journal of Clinical Practice"},{"key":"BF03259953_CR30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.45.4.272","volume":"45","author":"M Doherty","year":"1986","unstructured":"Doherty M, Holt M, Macmillan P, Watt I, Dieppe P. A reappraisal of \u2018analgesic\u2019 hip. Annals of the Rheumatic Diseases 45: 272\u2013279, 1986","journal-title":"Annals of the Rheumatic Diseases"},{"key":"BF03259953_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)30649-X","volume":"199","author":"GG Duggin","year":"1976","unstructured":"Duggin GG, Mudge GH. Analgesic nephropathy: renal distribution of acetaminophen and its conjugates. Journal of Pharmacology and Experimental Therapeutics 199: 1\u20139, 1976","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259953_CR32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/bmj.293.6540.202-c","volume":"293","author":"AM Dunn","year":"1986","unstructured":"Dunn AM, Buckley BM. Non-steroidal anti-inflammatory drugs and the kidney. British Medical Journal 293: 202\u2013203, 1986","journal-title":"British Medical Journal"},{"key":"BF03259953_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.2.5753.87","volume":"2","author":"OM Edwards","year":"1971","unstructured":"Edwards OM, Edwards P, Huskisson EC, Taylor RT. Paracetamol and renal damage. British Medical Journal 2: 87\u201389, 1971","journal-title":"British Medical Journal"},{"key":"BF03259953_CR34","first-page":"615","volume":"11","author":"HC Elliot","year":"1962","unstructured":"Elliot HC. Reduced adrenocortical steroid excretion rates in man following aspirin administration. Metabolism 11: 615\u2013618, 1962","journal-title":"Metabolism"},{"key":"BF03259953_CR35","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0140-6736(71)90102-4","volume":"2","author":"NR Farid","year":"1971","unstructured":"Farid NR, Johnson RL, Low WT. Haemolytic reaction to mefenamic acid. Lancet 2: 382, 1971","journal-title":"Lancet"},{"key":"BF03259953_CR36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0640407","volume":"64","author":"L Favre","year":"1983","unstructured":"Favre L, Glasson Ph, Riondel A, Valloton MD. Interaction of diuretics and NSAIDs in man. Clinical Sciences 64: 407\u2013415, 1983","journal-title":"Clinical Sciences"},{"key":"BF03259953_CR37","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/jama.1980.03310100045031","volume":"244","author":"JW Findling","year":"1980","unstructured":"Findling JW, Beckstrom D, Rawsthorne L, Kozin F, Itskovitz H. Indomethacin-induced hyperkalaemia in three patients with gouty arthritis. Journal of the American Medical Association 244: 1127\u20131128, 1980","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF03260008","volume":"2","author":"RJ Flanagan","year":"1987","unstructured":"Flanagan RJ. The role of acetylcysteine in clinical toxicology. Medical Toxicology 2: 93\u2013104, 1987","journal-title":"Medical Toxicology"},{"key":"BF03259953_CR39","first-page":"353","volume-title":"Antirheumatic drugs","author":"PD Fowler","year":"1983","unstructured":"Fowler PD. Phenylbutazone. In Huskinsson EC (Ed.) Antirheumatic drugs, pp. 353\u2013370, Praeger Press, Eastbourne 1983"},{"key":"BF03259953_CR40","first-page":"344","volume":"26","author":"PD Fowler","year":"1967","unstructured":"Fowler PD. Marrow toxicity of the pyrazoles. Annals of the Rheumatic Diseases 26: 344\u2013345, 1967","journal-title":"Annals of the Rheumatic Diseases"},{"key":"BF03259953_CR41","first-page":"41","volume-title":"Choosing NSAID therapy","author":"PD Fowler","year":"1985","unstructured":"Fowler PD. Major toxic reactions. In Hart & Klinenberg (Eds) Choosing NSAID therapy, pp. 41\u201357, ADIS Press, Auckland, 1985"},{"key":"BF03259953_CR42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/rheumatology\/21.1.42","volume":"21","author":"PD Fowler","year":"1982","unstructured":"Fowler PD, Crook PR, Hothersall TE. Diclofenac sodium and thyroid function tests. Rheumatology and Rehabilitation 21: 42\u201347, 1982","journal-title":"Rheumatology and Rehabilitation"},{"issue":"2","key":"BF03259953_CR43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/030006057700502S22","volume":"5","author":"PD Fowler","year":"1977","unstructured":"Fowler PD, Faragher EB. Drug and non-drug factors affecting adverse reactions to pyrazoles. International Journal of Medical Research 5 (Suppl. 2): 108\u2013120, 1977","journal-title":"International Journal of Medical Research"},{"key":"BF03259953_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/rheumatology\/14.2.71","volume":"14","author":"PD Fowler","year":"1975","unstructured":"Fowler PD, Woolfe D, Alexander S. Phenylbutazone and hepatitis. Rheumatology and Rehabilitation 14: 71\u201375, 1975","journal-title":"Rheumatology and Rehabilitation"},{"key":"BF03259953_CR45","first-page":"8835","volume":"287","author":"RW Fowler","year":"1983","unstructured":"Fowler RW, Arnold KG. Non-steroidal analgesic and anti-inflammatory agents. British Medical Journal 287: 8835, 1983","journal-title":"British Medical Journal"},{"key":"BF03259953_CR46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/pgmj.53.619.243","volume":"53","author":"BG Gazzard","year":"1977","unstructured":"Gazzard BG, Hughes RD, Widdop B, Goulding R, Davis M, et al. Early prediction of the outcome of paracetamol overdose. Postgraduate Medical Journal 53: 243, 1977","journal-title":"Postgraduate Medical Journal"},{"key":"BF03259953_CR47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.1.5906.501","volume":"1","author":"RH Girdwood","year":"1974","unstructured":"Girdwood RH. Death after taking medicaments. British Medical Journal 1: 501\u2013504, 1974","journal-title":"British Medical Journal"},{"key":"BF03259953_CR48","first-page":"201","volume-title":"Antirheumatic drugs","author":"AAJ Goldberg","year":"1983","unstructured":"Goldberg AAJ, Godfrey KE. Fenclofenac. In Huskinsson EC (Ed.) Antirheumatic drugs, pp. 201\u2013232, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR49","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archinte.1981.00340060110027","volume":"141","author":"RC Goldszer","year":"1981","unstructured":"Goldszer RC, Coodley EL, Rosner MJ, Simons WM, Schwartz AB. Hyperkalaemia associated with indomethacin. Archives of Internal Medicine 141: 802\u2013804, 1981","journal-title":"Archives of Internal Medicine"},{"key":"BF03259953_CR50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.1913.04340130005003","volume":"60","author":"PJ Hanzlik","year":"1913","unstructured":"Hanzlik PJ. A study of the toxicity of salicylates based on clinical statistics. Journal of the American Medical Association 60: 957\u2013962, 1913","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR51","first-page":"499","volume":"122","author":"B Harvald","year":"1960","unstructured":"Harvald B, Pedersen J. Shock som patogenetisk faklar ved papillitis necrotican i renova. Ugeskrift For Laeger 122: 499, 1960","journal-title":"Ugeskrift For Laeger"},{"key":"BF03259953_CR52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF02030974","volume":"5","author":"G Husby","year":"1986","unstructured":"Husby G, Holme I, Rugstead HE, Herland OB, Gierksky KE. A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis. Clinical Rheumatology 5: 84\u201391, 1986","journal-title":"Clinical Rheumatology"},{"key":"BF03259953_CR53","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/bmj.1.6075.1500","volume":"1","author":"WHW Inman","year":"1977","unstructured":"Inman WHW. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. British Medical Journal 1: 1500\u20131505, 1977","journal-title":"British Medical Journal"},{"key":"BF03259953_CR54","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"International AgranulocytosisAplastic Anemia Study","year":"1986","unstructured":"International Agranulocytosis and Aplastic Anemia Study. Risk of agranulocytosis and aplastic anemia. Journal of the American Medical Association 256: 1749\u20131757, 1986","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR55","first-page":"61","volume":"17","author":"MK Jensen","year":"1972","unstructured":"Jensen MK. Phenylbutazone, chloramphenicol and mammalian chromosomes. Humangenetik 17: 61 1972","journal-title":"Humangenetik"},{"issue":"4","key":"BF03259953_CR56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00003495-198600324-00009","volume":"32","author":"P Kincaid-Smith","year":"1986","unstructured":"Kincaid-Smith P. Effects of non-narcotic analgesics on the kidney. Drugs 32 (Suppl. 4): 109\u2013128, 1986","journal-title":"Drugs"},{"key":"BF03259953_CR57","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(78)92327-9","volume":"2","author":"A Kornberg","year":"1978","unstructured":"Kornberg A, Polliak A. Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet 2: 1159, 1978","journal-title":"Lancet"},{"key":"BF03259953_CR58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/ard.45.8.663","volume":"45","author":"M Laakso","year":"1986","unstructured":"Laakso M, Mutro O, Isomaki H, Koota K. Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis. Annals of Rheumatic Diseases 45: 663\u2013667, 1986","journal-title":"Annals of Rheumatic Diseases"},{"key":"BF03259953_CR59","first-page":"203S","volume":"55","author":"JA Lopez-Ovejero","year":"1978","unstructured":"Lopez-Ovejero JA, Weber MA, Drayer JIM, Sealy JE, Laragh JH. Effects of indomethacin alone and during diuretic and -adrenoreceptor-blockage therapy on blood pressure and the renin system in essential hypertension. Clinical Science and Molecular Medicine 55 (Suppl.): 203S\u2013205S, 1978","journal-title":"Clinical Science and Molecular Medicine"},{"key":"BF03259953_CR60","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0091-6749(72)90014-0","volume":"50","author":"JR McDonald","year":"1972","unstructured":"McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma: detection by oral challenge. Journal of Allergy and Clinical Immunology 50: 198\u2013207, 1972","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"BF03259953_CR61","first-page":"125","volume":"7","author":"RM Mason","year":"1968","unstructured":"Mason RM. The treatment of gout. Prescribers Journal 7: 125\u2013131, 1968","journal-title":"Prescribers Journal"},{"key":"BF03259953_CR62","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.169.3941.198","volume":"169","author":"I Mauer","year":"1970","unstructured":"Mauer I, Weinstein D, Solomon MH. Acetylsalicylic acid: no chromosome damage in human leukocytes. Science 169: 198\u2013201, 1970","journal-title":"Science"},{"key":"BF03259953_CR63","first-page":"41","volume":"16","author":"LF Meisner","year":"1972","unstructured":"Meisner LF, Inhorn SL. Chemically induced chromosome changes in human cells in vitro. Acta Cytologica 16: 41\u201347, 1972","journal-title":"Acta Cytologica"},{"key":"BF03259953_CR64","first-page":"345","volume":"293","author":"TJ Meredith","year":"1986","unstructured":"Meredith TJ, Prescott LF, Vale JA. Why do patients still die from paracetamol poisoning? Lancet 293: 345\u2013346, 1986","journal-title":"Lancet"},{"issue":"6","key":"BF03259953_CR65","first-page":"100","volume":"7","author":"W Mikulaschek","year":"1980","unstructured":"Mikulaschek W. Long term safety of benoxaprofen. Journal of Rheumatology 7 (Suppl. 6): 100\u2013107, 1980","journal-title":"Journal of Rheumatology"},{"key":"BF03259953_CR66","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780190121","volume":"19","author":"JJ Miller","year":"1976","unstructured":"Miller JJ, Weissman DB. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis. Arthritis and Rheumatism 19: 115\u2013118, 1976","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259953_CR67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000204146","volume":"8","author":"S Moeschlin","year":"1952","unstructured":"Moeschlin S, Wagner K. Agranuloctosis due to occurrence of leucocyte agglutinins. Acta Haematologica 8: 29\u201341, 1952","journal-title":"Acta Haematologica"},{"key":"BF03259953_CR68","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1445-5994.1973.tb04299.x","volume":"3","author":"RS Nanra","year":"1973","unstructured":"Nanra RS, Chirawong P, Kincaid-Smith P. Medullary ischacmia in experimental analgesic nephropathy: the pathogenesis of renal papillary necrosis. Australian and New Zealand Medical Journal 3: 580, 1973","journal-title":"Australian and New Zealand Medical Journal"},{"key":"BF03259953_CR69","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.1978.11","volume":"13","author":"RS Nanra","year":"1978","unstructured":"Nanra RS, Stuart-Taylor J, deLeon AH, White KH. Analgesic nephropathy: etiology, clinical syndrome and clinicopathologic correlations in Australia. Kidney International 13: 79\u201392, 1978","journal-title":"Kidney International"},{"unstructured":"Office of Population Censuses and Surveys. Mortality statistics: accidents and violence. Series BH4 (table 10). Her Majesty\u2019s Stationary Office, London, 1984","key":"BF03259953_CR70"},{"key":"BF03259953_CR71","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0016-5085(77)80162-5","volume":"72","author":"T O\u2019Gorman","year":"1981","unstructured":"O\u2019Gorman T, Koff RS. Salicylate hepatitis. Gastroenterology 72: 726\u2013728, 1977. O\u2019Laughlin JC, Hoftiezer JW, Mahoney J, Ivey KJ. Effect of aspirin on the human stomach in normals: endoscopic comparison of damage produced one hour, 24 hours and 2 weeks after administration. Scandinavian Journal of Gastroenterology 16 (Suppl. 67): 211-214, 1981","journal-title":"Gastroenterology"},{"key":"BF03259953_CR72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(77)90154-6","volume":"43","author":"E Oliw","year":"1987","unstructured":"Oliw E, \u00c4ngaard E, Fredholm BB. Effect of indomethacin on the renal effects of theophylline. European Journal of Pharmacology 43: 9\u201316, 1987","journal-title":"European Journal of Pharmacology"},{"issue":"2A","key":"BF03259953_CR73","first-page":"77","volume":"72","author":"N Pitts","year":"1982","unstructured":"Pitts N. Efficacy and safety of piroxicam. American Journal of Medicine 72 (Suppl. 2A): 77\u201387, 1982","journal-title":"American Journal of Medicine"},{"key":"BF03259953_CR74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-198223010-00004","volume":"23","author":"LF Prescott","year":"1982","unstructured":"Prescott LF. Analgesic nephropathy. Drugs 23: 75\u2013159, 1982","journal-title":"Drugs"},{"key":"BF03259953_CR75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2165\/00003495-198325030-00002","volume":"25","author":"LF Prescott","year":"1983","unstructured":"Prescott LF. Paracetamol overdose: pharmacological considerations and clinical management. Drugs 25: 290\u2013314, 1983","journal-title":"Drugs"},{"key":"BF03259953_CR76","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(80)90987-3","volume":"1","author":"WA Ratcliffe","year":"1980","unstructured":"Ratcliffe WA, Hazleton RA, Thompson JA. Effect of fenclofenac on thyroid function tests. Lancet 1: 432, 1980","journal-title":"Lancet"},{"key":"BF03259953_CR77","first-page":"44","volume-title":"Textbook of adverse drug reactions","author":"MD Rawlins","year":"1977","unstructured":"Rawlins MD, Thompson JW. Pathogenesis of adverse reactions. In Davies DM(Ed.) Textbook of adverse drug reactions, p. 44, Oxford University Press, Oxford, 1977"},{"key":"BF03259953_CR78","first-page":"421","volume-title":"Antirheumatic drugs","author":"AR Rhymer","year":"1983","unstructured":"Rhymer AR. Sulindac. In Huskisson EC (Ed.) Antirheumatic drugs, pp. 421\u2013438, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR79","first-page":"265","volume-title":"Antirheumatic drugs","author":"AR Rhymer","year":"1983","unstructured":"Rhymer AR, Gingos DC. Indomethacin. In Huskisson EC (Ed.) Antirheumatic drugs, pp. 265\u2013278, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR80","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF02939815","volume":"140","author":"JH Robertson","year":"1971","unstructured":"Robertson JH, Kennedy CC, Hill CM. Haemolytic anaemia associated with mefenamic acid. Irish Journal of Medical Science 140: 226, 1971","journal-title":"Irish Journal of Medical Science"},{"key":"BF03259953_CR81","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bmj.294.6565.147","volume":"294","author":"AC Rossi","year":"1987","unstructured":"Rossi AC, Hsu JP, Faich GA. Ulcerogenicity of piroxicam: an analysis of spontaneously reported data. British Medical Journal 294: 147\u2013150, 1987","journal-title":"British Medical Journal"},{"issue":"2","key":"BF03259953_CR82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/030006057700502S13","volume":"5","author":"WH Rushford","year":"1977","unstructured":"Rushford WH, Fowler PD. Butacote: the first assessment in general practice. Journal of International Medical Research 5 (Suppl. 2): 67\u2013669, 1977","journal-title":"Journal of International Medical Research"},{"key":"BF03259953_CR83","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/bmj.2.5759.428","volume":"2","author":"AS Russell","year":"1971","unstructured":"Russell AS, Sturge RA, Smith MA. Serum transaminases during salicylate therapy. British Medical Journal 2: 428\u2013429, 1971","journal-title":"British Medical Journal"},{"key":"BF03259953_CR84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archderm.1976.01630260039011","volume":"112","author":"WM Sams Jr","year":"1976","unstructured":"Sams Jr WM, Thorne EG, Small P, Moss MF, Mclntosh RM, et al. Leukocytoclastic vasculitis. Archives of Dermatology 112: 219\u2013226, 1976","journal-title":"Archives of Dermatology"},{"doi-asserted-by":"crossref","unstructured":"Sasisekhar PR, Penn RG, Haslock I, Wright V. A comparison of aspirin and benorylate in the treatment of rheumatoid arthritis. Rheumatology and Rehabilitation (Suppl.): 31-38, 1973","key":"BF03259953_CR85","DOI":"10.1093\/rheumatology\/XII.suppl.31"},{"key":"BF03259953_CR86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-3565(25)25026-1","volume":"228","author":"V Schwertschlag","year":"1986","unstructured":"Schwertschlag V, Gerber JG, Barnes JS, Nies AS. A dual effect of non-steroidal anti-inflammatory drugs on renal water handling in humans. Journal of Pharmacology and Experimental Therapeutics 228: 653\u2013658, 1986","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259953_CR87","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/bmj.3.5617.534","volume":"3","author":"GL Scott","year":"1968","unstructured":"Scott GL, Myles AB, Bacon PA. Autoimmune haemolytic anaemia and mefenamic acid. British Medical Journal 3: 534\u2013535, 1968","journal-title":"British Medical Journal"},{"key":"BF03259953_CR88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.1780190205","volume":"19","author":"WE Seaman","year":"1976","unstructured":"Seaman WE, Plotz PH. Effect of aspirin on liver tests in patients with RA or SLE and in normal volunteers. Arthritis and Rheumatism 19: 155\u2013160, 1976","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259953_CR89","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1185\/03007997709108986","volume":"5","author":"FE Sheldrake","year":"1977","unstructured":"Sheldrake FE, Webber JM, Marsh BD. A long term assessment of flurbiprofen. Current Medical Research and Opinion 5: 106\u2013116, 1977","journal-title":"Current Medical Research and Opinion"},{"key":"BF03259953_CR90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.0954-6820.1982.tb03221.x","volume":"212","author":"M Silanpaa","year":"1982","unstructured":"Silanpaa M, Kasanen A, Elonen A. Changes of panorama in renal disease mortality in Finland after phenacetin restriction. Acta Medica Scandinavica 212: 313\u2013317, 1982","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259953_CR91","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/bmj.2.5760.494","volume":"2","author":"AP Smith","year":"1971","unstructured":"Smith AP. Response of aspirin-allergic patients to challenge by some analgesics in common use. British Medical Journal 2: 494\u2013496, 1971","journal-title":"British Medical Journal"},{"key":"BF03259953_CR92","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.1984.03350110033025","volume":"252","author":"RS Stern","year":"1984","unstructured":"Stern RS, Bigby M. Cutaneous reactions to non-steroidal anti-inflammatory drugs. Journal of the American Medical Association 252: 1433\u20131437, 1984","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR93","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/ard.30.5.487","volume":"30","author":"AC Stevenson","year":"1971","unstructured":"Stevenson AC, Patel AR, Bedford J, Hill AGS, Hill HFH. Chromosomal studies-in patients taking phenylbutazone. Annals of the Rheumatic Diseases 30: 487\u2013500, 1971","journal-title":"Annals of the Rheumatic Diseases"},{"unstructured":"Swain MC, Smith DW, Goldberg AAJ. Fenclofenac: a five year review of patient tolerance. In Fenclofenac in Arthritis, Royal Society of Medicine, International Congress Series No 28, p. 73, Academic Press, 1980","key":"BF03259953_CR94"},{"key":"BF03259953_CR95","first-page":"350","volume":"21","author":"DPM Symmons","year":"1983","unstructured":"Symmons DPM, Kendall MJ, Rees JA, Hind ID. The effect of flurbiprofen on the response to frusemide in healthy volunteers. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 21: 350\u2013354, 1983","journal-title":"International Journal of Clinical Pharmacology, Therapeutics and Toxicology"},{"issue":"4","key":"BF03259953_CR96","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2165\/00003495-198600324-00011","volume":"32","author":"A Szczeklik","year":"1986","unstructured":"Szczeklik A. Analgesics allergy and asthma. Drugs 32 (Suppl. 4): 148\u2013163, 1986","journal-title":"Drugs"},{"key":"BF03259953_CR97","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00587792","volume":"297","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawaska-Mysik G. Participation of prostaglandins in pathogenesis of aspirin-sensitive asthma. Naunyn Schmiedeberg\u2019s Archives of Pharmacology 297 (Suppl.): 99, 1977a","journal-title":"Naunyn Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"BF03259953_CR98","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0091-6749(77)90106-3","volume":"60","author":"A Szczeklik","year":"1977","unstructured":"Szczeklik A, Gryglewski RJ, Czerniawaska-Mysik G. Clinical patterns of hypersensitivity of non-steroidal anti-inflammatory drugs and their pathogenesis. Journal of Allergy and Clinical Immunology 60: 276\u2013284, 1977b","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"BF03259953_CR99","volume-title":"Antirheumatic drugs, 307\u2013318","author":"JN Tamiser","year":"1983","unstructured":"Tamiser JN. Ketoprofen. In Huskisson EC (Ed.) Antirheumatic drugs, 307\u2013318, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR100","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1001\/jama.1979.03290510040025","volume":"241","author":"SY Tan","year":"1979","unstructured":"Tan SY, Shapiro, Kish MA. Reversible acute renal failure induced by indomethacin. Journal of the American Medical Association 241: 2732\u20132733, 1979","journal-title":"Journal of the American Medical Association"},{"key":"BF03259953_CR101","first-page":"97","volume-title":"Antirheumatic Drugs","author":"JS Templeton","year":"1983","unstructured":"Templeton JS. Azapropazone. In Huskisson EC (Ed.) Antirheumatic Drugs, pp. 97\u2013116, Praeger Publishers, Eastbourne, 1983"},{"key":"BF03259953_CR102","first-page":"157","volume-title":"Antirheumatic drugs","author":"C Winzun van","year":"1983","unstructured":"van Winzun C, Verhaest L, von Poelnitz M. Diflunis. In Huskisson EC (Ed.) Antirheumatic drugs, pp. 157\u2013182, Praeger Press, Eastbourne, 1983"},{"key":"BF03259953_CR103","first-page":"57","volume-title":"Phenylbutazone","author":"HK Rechenberg von","year":"1962","unstructured":"von Rechenberg HK. Phenylbutazone, pp. 57\u201361, Edward Arnold, London, 1962a"},{"key":"BF03259953_CR104","first-page":"106","volume-title":"Phenylbutazone","author":"HK Rechenberg von","year":"1962","unstructured":"von Rechenberg HK. Phenylbutazone, p. 106, Edward Arnold, London, 1962b"},{"key":"BF03259953_CR105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-91-1-47","volume":"91","author":"JJ Walshe","year":"1979","unstructured":"Walshe JJ, Venuto RC. Acute oliguric renal failure induced by indomethacin. Annals of Internal Medicine 91: 47\u201349, 1979","journal-title":"Annals of Internal Medicine"},{"key":"BF03259953_CR106","first-page":"1","volume-title":"Advances in inflammatory research, Vol. 6","author":"JCP Weber","year":"1984","unstructured":"Weber JCP. Epidemiology of adverse reactions to non-steroidal anti-inflammatory drugs. In Rainsford & Velo (Eds) Advances in inflammatory research, Vol. 6, pp. 1\u20137, Raven Press, New York, 1984"},{"key":"BF03259953_CR107","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJM195506232522508","volume":"252","author":"JI Weissman","year":"1955","unstructured":"Weissman JI, Bloom B. Anuria following phenylbutazone therapy. New England Journal of Medicine 252: 1086\u20131087, 1955","journal-title":"New England Journal of Medicine"},{"key":"BF03259953_CR108","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/j.1552-4604.1982.tb05705.x","volume":"22","author":"RL Williams","year":"1982","unstructured":"Williams RL, Davies R, Berman RS, Holmes GI, Huber P, et al. Hydrochlorothiazide pharmacokinetics and pharmacologic effect and influence of indomethacin. Journal of Clinical Pharmacology 22: 32\u201341, 1982","journal-title":"Journal of Clinical Pharmacology"},{"key":"BF03259953_CR109","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(86)91271-7","volume":"1","author":"DG Wong","year":"1986","unstructured":"Wong DG, Spence JD, Lamki L, Freeman D, McDonald JWD. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by \u03b2-blockers and diuretics. Lancet 1: 997\u20131000, 1986","journal-title":"Lancet"},{"key":"BF03259953_CR110","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/bmj.283.6293.714","volume":"283","author":"AC Yeung Laiwah","year":"1981","unstructured":"Yeung Laiwah AC, Mactier RA. Antagonistic effects of non-steroidal anti-inflammatory drugs on frusemide-induced cardiac failure. British Medical Journal 283: 714, 1981","journal-title":"British Medical Journal"},{"key":"BF03259953_CR111","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF03260010","volume":"2","author":"HJ Zimmerman","year":"1987","unstructured":"Zimmerman HJ, Lewis JH. Drug-induced cholestasis. Medical Toxicology 2: 112\u2013160, 1987","journal-title":"Medical Toxicology"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259953.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259953\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:56:34Z","timestamp":1745362594000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259953"}},"subtitle":["A Comparative Review of Side Effects"],"short-title":[],"issued":{"date-parts":[[1987,10]]},"references-count":111,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1987,10]]}},"alternative-id":["BF03259953"],"URL":"https:\/\/doi.org\/10.1007\/bf03259953","relation":{},"ISSN":["0112-5966"],"issn-type":[{"type":"print","value":"0112-5966"}],"subject":[],"published":{"date-parts":[[1987,10]]}}}